Lakefront Biotherapeutics NV Share Price & Technical Analysis
GLPG · $27.73
Healthcare / Biotechnology
$27.73
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-1% return in May, 4% avg return in past 3 year May month.
-15% return in 2026, -7% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 3% | 0% | -11% | -7% | -1% | – | – | – | – | – | – | – | -15% |
| 25 | -18% | 15% | -6% | 7% | 7% | -3% | 17% | -4% | 11% | -10% | -1% | 3% | 18% |
| 24 | -7% | -6% | -8% | -11% | -2% | -10% | 8% | 7% | -1% | -8% | 3% | -1% | -38% |
| 23 | -1% | -15% | 3% | 2% | 6% | -1% | 2% | -10% | -10% | -3% | 14% | 9% | -2% |
| 22 | 23% | -1% | -8% | -8% | -7% | 1% | -7% | -3% | -14% | 8% | -15% | 11% | -20% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.86B
P/E ratio
3.18
52W high
$37.78
52W low
$26.62
Volume
2,86,745
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Lakefront Biotherapeutics NV share price today?
- Lakefront Biotherapeutics NV (GLPG) last traded around $27.73 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GLPG have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GLPG. Download the app for real-time alerts.
- How can I analyze Lakefront Biotherapeutics NV stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.